Prognostic significance of Ki-67 and p53 immunoreactivity in cutaneous squamous cell carcinomas

Atiya Mansoor, Phillip H. McKee, Julie A. Simpson, Brigid McGuire, Carl Hobbs

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

In this retrospective study we have investigated the expression of Ki- 67 and p53 in 175 random cases of cutaneous squamous cell carcinomas by using the monoclonal antibodies MIB-1 and DO-1, respectively. The expression of these antibodies was compared with various histological parameters of prognostic significance. The staining results were also compared with the clinical outcome of the patients. MIB-1 and DO-1 staining showed statistically significant correlation with histopathological grade of the tumor (p <0.0001 and p = 0.0016, respectively). The degree of immunolabelling of these antibodies also showed significant correlation with tumor depth and tumor thickness (MIB-1 thickness p = 0.02 and depth p = 0.026, and DO-1 thickness p = 0.014 and depth p = 0.005). The majority of the squamous cell carcinomas in our series were Clark's level IV, which therefore did not correlate with the extent of immunoreactivity (MIB-1, p = 0.098; and DO-1, p = 0.885). Mean length of clinical follow-up was 5.2 years. Aggressive tumor behaviour was seen in 17 patients (10.6%) with 6.9% and 3.4% local recurrences and nodal metastasis respectively. A total of 89.4% patients remained disease-free following their definitive surgical treatment. Vulval skin represented the commonest site associated with unfavourable clinical outcome (five of 17 cases). A large number of squamous cell carcinomas in this poor prognosis group showed a high prevalence of immunoreactivity of the antibodies but this did not achieve any statistical significance. We conclude that Ki-67 and p53 expression in cutaneous squamous carcinoma is not an independent predictor of prognosis.

Original languageEnglish (US)
Pages (from-to)351-357
Number of pages7
JournalAmerican Journal of Dermatopathology
Volume18
Issue number4
DOIs
StatePublished - 1996
Externally publishedYes

Fingerprint

Squamous Cell Carcinoma
Skin
Antibodies
Neoplasms
Staining and Labeling
Retrospective Studies
Neoplasm Metastasis
Recurrence
Therapeutics

Keywords

  • Immunohistochemistry
  • Ki-67
  • P53
  • Prognosis
  • Squamous cell carcinoma of the skin

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Dermatology

Cite this

Prognostic significance of Ki-67 and p53 immunoreactivity in cutaneous squamous cell carcinomas. / Mansoor, Atiya; McKee, Phillip H.; Simpson, Julie A.; McGuire, Brigid; Hobbs, Carl.

In: American Journal of Dermatopathology, Vol. 18, No. 4, 1996, p. 351-357.

Research output: Contribution to journalArticle

Mansoor, Atiya ; McKee, Phillip H. ; Simpson, Julie A. ; McGuire, Brigid ; Hobbs, Carl. / Prognostic significance of Ki-67 and p53 immunoreactivity in cutaneous squamous cell carcinomas. In: American Journal of Dermatopathology. 1996 ; Vol. 18, No. 4. pp. 351-357.
@article{f7c10c639e3e4b2d93dbe79dc310030d,
title = "Prognostic significance of Ki-67 and p53 immunoreactivity in cutaneous squamous cell carcinomas",
abstract = "In this retrospective study we have investigated the expression of Ki- 67 and p53 in 175 random cases of cutaneous squamous cell carcinomas by using the monoclonal antibodies MIB-1 and DO-1, respectively. The expression of these antibodies was compared with various histological parameters of prognostic significance. The staining results were also compared with the clinical outcome of the patients. MIB-1 and DO-1 staining showed statistically significant correlation with histopathological grade of the tumor (p <0.0001 and p = 0.0016, respectively). The degree of immunolabelling of these antibodies also showed significant correlation with tumor depth and tumor thickness (MIB-1 thickness p = 0.02 and depth p = 0.026, and DO-1 thickness p = 0.014 and depth p = 0.005). The majority of the squamous cell carcinomas in our series were Clark's level IV, which therefore did not correlate with the extent of immunoreactivity (MIB-1, p = 0.098; and DO-1, p = 0.885). Mean length of clinical follow-up was 5.2 years. Aggressive tumor behaviour was seen in 17 patients (10.6{\%}) with 6.9{\%} and 3.4{\%} local recurrences and nodal metastasis respectively. A total of 89.4{\%} patients remained disease-free following their definitive surgical treatment. Vulval skin represented the commonest site associated with unfavourable clinical outcome (five of 17 cases). A large number of squamous cell carcinomas in this poor prognosis group showed a high prevalence of immunoreactivity of the antibodies but this did not achieve any statistical significance. We conclude that Ki-67 and p53 expression in cutaneous squamous carcinoma is not an independent predictor of prognosis.",
keywords = "Immunohistochemistry, Ki-67, P53, Prognosis, Squamous cell carcinoma of the skin",
author = "Atiya Mansoor and McKee, {Phillip H.} and Simpson, {Julie A.} and Brigid McGuire and Carl Hobbs",
year = "1996",
doi = "10.1097/00000372-199608000-00004",
language = "English (US)",
volume = "18",
pages = "351--357",
journal = "American Journal of Dermatopathology",
issn = "0193-1091",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Prognostic significance of Ki-67 and p53 immunoreactivity in cutaneous squamous cell carcinomas

AU - Mansoor, Atiya

AU - McKee, Phillip H.

AU - Simpson, Julie A.

AU - McGuire, Brigid

AU - Hobbs, Carl

PY - 1996

Y1 - 1996

N2 - In this retrospective study we have investigated the expression of Ki- 67 and p53 in 175 random cases of cutaneous squamous cell carcinomas by using the monoclonal antibodies MIB-1 and DO-1, respectively. The expression of these antibodies was compared with various histological parameters of prognostic significance. The staining results were also compared with the clinical outcome of the patients. MIB-1 and DO-1 staining showed statistically significant correlation with histopathological grade of the tumor (p <0.0001 and p = 0.0016, respectively). The degree of immunolabelling of these antibodies also showed significant correlation with tumor depth and tumor thickness (MIB-1 thickness p = 0.02 and depth p = 0.026, and DO-1 thickness p = 0.014 and depth p = 0.005). The majority of the squamous cell carcinomas in our series were Clark's level IV, which therefore did not correlate with the extent of immunoreactivity (MIB-1, p = 0.098; and DO-1, p = 0.885). Mean length of clinical follow-up was 5.2 years. Aggressive tumor behaviour was seen in 17 patients (10.6%) with 6.9% and 3.4% local recurrences and nodal metastasis respectively. A total of 89.4% patients remained disease-free following their definitive surgical treatment. Vulval skin represented the commonest site associated with unfavourable clinical outcome (five of 17 cases). A large number of squamous cell carcinomas in this poor prognosis group showed a high prevalence of immunoreactivity of the antibodies but this did not achieve any statistical significance. We conclude that Ki-67 and p53 expression in cutaneous squamous carcinoma is not an independent predictor of prognosis.

AB - In this retrospective study we have investigated the expression of Ki- 67 and p53 in 175 random cases of cutaneous squamous cell carcinomas by using the monoclonal antibodies MIB-1 and DO-1, respectively. The expression of these antibodies was compared with various histological parameters of prognostic significance. The staining results were also compared with the clinical outcome of the patients. MIB-1 and DO-1 staining showed statistically significant correlation with histopathological grade of the tumor (p <0.0001 and p = 0.0016, respectively). The degree of immunolabelling of these antibodies also showed significant correlation with tumor depth and tumor thickness (MIB-1 thickness p = 0.02 and depth p = 0.026, and DO-1 thickness p = 0.014 and depth p = 0.005). The majority of the squamous cell carcinomas in our series were Clark's level IV, which therefore did not correlate with the extent of immunoreactivity (MIB-1, p = 0.098; and DO-1, p = 0.885). Mean length of clinical follow-up was 5.2 years. Aggressive tumor behaviour was seen in 17 patients (10.6%) with 6.9% and 3.4% local recurrences and nodal metastasis respectively. A total of 89.4% patients remained disease-free following their definitive surgical treatment. Vulval skin represented the commonest site associated with unfavourable clinical outcome (five of 17 cases). A large number of squamous cell carcinomas in this poor prognosis group showed a high prevalence of immunoreactivity of the antibodies but this did not achieve any statistical significance. We conclude that Ki-67 and p53 expression in cutaneous squamous carcinoma is not an independent predictor of prognosis.

KW - Immunohistochemistry

KW - Ki-67

KW - P53

KW - Prognosis

KW - Squamous cell carcinoma of the skin

UR - http://www.scopus.com/inward/record.url?scp=0029796319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029796319&partnerID=8YFLogxK

U2 - 10.1097/00000372-199608000-00004

DO - 10.1097/00000372-199608000-00004

M3 - Article

C2 - 8879297

AN - SCOPUS:0029796319

VL - 18

SP - 351

EP - 357

JO - American Journal of Dermatopathology

JF - American Journal of Dermatopathology

SN - 0193-1091

IS - 4

ER -